CLINICAL_TRIALS
trial_result
· 2011-05-04
Clinical Trial Update: CEP-701 for PH-negative Myelofibrosis [Phase 2]
Summary
Phase 2 clinical trial of CEP-701 (lestaurtinib) for PH-negative myelofibrosis completed, with results posted in May 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2011-05-04